Insys Therapeutics (INSY) Misses Q1 EPS by 1c

May 8, 2018 4:01 PM

Insys Therapeutics (NASDAQ: INSY) reported Q1 EPS of ($0.19), $0.01 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $23.9 million versus the consensus estimate of $25.66 million.

For earnings history and earnings-related data on Insys Therapeutics (INSY) click here.


Earnings Guidance

Next Articles